Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1166923

registered interest
date	28/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to widen the NHS England criteria under which diabetes patients can receive the Freestyle Libre glucose monitoring device on prescription to include type 2 diabetics.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	6361
answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>Clinical commissioning groups are responsible for commissioning diabetes services for their local populations. They are also expected to take National Institute for Health and Care Excellence (NICE) guidelines into consideration when making their decisions. NICE currently recommends not routinely offering self-monitoring of blood glucose levels for adults with type 2 diabetes unless the person:</p><p> </p><p>- is on insulin;</p><p>- or there is evidence of hypoglycaemic episodes;</p><p>- or the person is on medication that may increase their risk of hypoglycaemia while driving or operating machinery;</p><p>- or the person is pregnant or is planning to become pregnant.</p><p> </p><p>The evidence base for the benefits and cost-effectiveness of flash glucose monitoring for people with type 2 diabetes is still developing, and NICE will continue to monitor the evidence and relevant research.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2019 10:24:50 answering member 4380 label Biography information for Jo Churchill
tabling member	4079 label Biography information for Julian Sturdy

1147016

registered interest
date	30/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many flash glucose monitors and sensors were prescribed from 1 April 2019 to 30 September 2019 in each CCG area.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	292093
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The information is not available in the format requested.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 08/10/2019 14:41:23 answering member 4380 label Biography information for Jo Churchill
tabling member	338 label Biography information for Keith Vaz

1134002

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has any plans to reintroduce blood glucose test strips on prescription for Type 2 diabetics.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	268495
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>Blood glucose test strips are available on prescription for people with type 2 diabetes. However, it is for clinical commissioning groups to make decisions on the commissioning of health services that best meet the needs of their local population, taking into account local priorities and needs.</p><p>The National Institute for Health and Care Excellence has published guidance on the management of type 2 Diabetes in adults. This guideline states:</p><p>“1.6.13 Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless:</p><ul><li>the person is on insulin or</li><li>there is evidence of hypoglycaemic episodes or</li><li>the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or</li><li>the person is pregnant, or is planning to become pregnant. For more information, see the NICE guideline on diabetes in pregnancy (<a href="http://www.nice.org.uk/guidance/ng3" target="_blank">http://www.nice.org.uk/guidance/ng3</a> ). There have been no recent changes to prescribing recommendations, although NHS England have recently consulted on proposals to prescribe test strips only that fall below a certain cost threshold.”</li></ul><p>More information is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations#blood-glucose-management-2" target="_blank">https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations#blood-glucose-management-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 02/07/2019 16:27:24 answering member 4455 label Biography information for Seema Kennedy
tabling member	4648 label Biography information for Laura Smith

1134003

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure all Type 2 diabetics have access to a glucose monitoring blood test every three months as standard.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	268496
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>Clinical commissioning groups are responsible for commissioning diabetes services for their local populations. They are also expected to take National Institute for Health and Care Excellence guidelines into consideration when making their decisions.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 02/07/2019 16:28:39 answering member 4455 label Biography information for Seema Kennedy
tabling member	4648 label Biography information for Laura Smith

1130040

registered interest
date	05/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan and NHS Planning Guidance commitments for 2019-20, what progress his Department has made on ensuring that patients with Type 1 diabetes benefit from life-changing flash glucose monitors in line with clinical guidelines; and if he will make a statement.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	260645
answer	answer is ministerial correction date of answer 14/06/2019 answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p><p>NHS England has published detailed criteria and supporting guidance at the following link:</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf</a></p><p>Clinical commissioning groups (CCGs) will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 14/06/2019 13:16:04 answering member 4455 label Biography information for Seema Kennedy
tabling member	4244 label Biography information for Jonathan Ashworth

1129746

registered interest
date	04/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase access to the Freestyle Libre monitoring device for diabetes patients.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	259980
answer	answer is ministerial correction date of answer 12/06/2019 answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p><p>NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf</a></p><p> </p><p>Clinical commissioning groups (CCGS) will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 259981 question first answered 12/06/2019 16:02:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	4079 label Biography information for Julian Sturdy

1129747

registered interest
date	04/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equitable access to the Freestyle Libre monitoring device for diabetes patients on the NHS.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	259981
answer	answer is ministerial correction date of answer 12/06/2019 answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p><p>NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf</a></p><p> </p><p>Clinical commissioning groups (CCGS) will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 259980 question first answered 12/06/2019 16:02:36 answering member 4455 label Biography information for Seema Kennedy
tabling member	4079 label Biography information for Julian Sturdy

1128877

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of people with type 1 diabetes who receive the Freestyle Libre system on the NHS.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	259138
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:48:09 answering member 4455 label Biography information for Seema Kennedy
tabling member	1566 label Biography information for Daniel Kawczynski

1122471

registered interest
date	23/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how he plans to fund prescriptions for Continuous Glucose Monitoring devices following their addition to the high-cost tariff-excluded devices list for 2019-20.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	246458
answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>The information requested on the number of prescriptions that have been issued for continuous glucose monitoring devices in each clinical commissioning group (CCG) area in not collected. CCGs are responsible for commissioning and funding diabetes services, including funding for prescriptions for continuous glucose monitoring devices, for their local populations. CCGs are clinically led organisations that have both the local knowledge and accountability to make commissioning and funding decisions in the best interests of their patients.</p><p>CCGs and providers should agree a local price for when these devices are in use, as they are not set by the national tariff but are in the high cost devices list in the tariff for 2019/20.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246459 question first answered 01/05/2019 15:59:56 answering member 4455 label Biography information for Seema Kennedy
tabling member	481 label Biography information for Sir George Howarth

1122475

registered interest
date	23/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many prescriptions have been issued for Continuous Glucose Monitoring devices in each clinical commissioning group area in (a) each year since 2015 and (b) 2019.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	246459
answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>The information requested on the number of prescriptions that have been issued for continuous glucose monitoring devices in each clinical commissioning group (CCG) area in not collected. CCGs are responsible for commissioning and funding diabetes services, including funding for prescriptions for continuous glucose monitoring devices, for their local populations. CCGs are clinically led organisations that have both the local knowledge and accountability to make commissioning and funding decisions in the best interests of their patients.</p><p>CCGs and providers should agree a local price for when these devices are in use, as they are not set by the national tariff but are in the high cost devices list in the tariff for 2019/20.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246458 question first answered 01/05/2019 15:59:56 answering member 4455 label Biography information for Seema Kennedy
tabling member	481 label Biography information for Sir George Howarth